ChemicalBook CAS DataBase List 53671-71-9

53671-71-9

Name	ICI 89406
CAS	53671-71-9
Molecular Formula	C19H22N4O3
MDL Number	MFCD00673934
Molecular Weight	354.4
MOL File	53671-71-9.mol

Chemical Properties

Melting point	155-156 °C(Solv: acetonitrile (75-05-8))
Boiling point	575.0±50.0 °C(Predicted)
density	1.25±0.1 g/cm3(Predicted)
storage temp.	Store at RT
solubility	Soluble in ethanol and to 100 mM in DMSO
form	Powder
pka	12.29±0.46(Predicted)
color	White to off-white

Hazard Information

Spectrum Detail

Supplier

3B Pharmachem (Wuhan) International Co.,Ltd.

Telephone 18930552037

Websitehttps://www.chemicalbook.com/ShowSupplierProductsList13285/0_EN.htm

Nanjing Chemlin Chemical Co., Ltd

Telephone025-83697070 13770331960

Websitehttp://www.echemlin.cn

SPIRO PHARMA

Telephone

Websitehttp://www.spiropharma.com.cn

Shanghai Kaiwei Chemical Technology Co., Ltd.

Telephone021-58461859 15821823057

Websitehttp://www.aivichem.com

Beijing Jin Ming Biotechnology Co., Ltd.

Telephone010-60605840

Websitehttp://www.jm-bio.com/

TargetMol Chemicals Inc.

Telephone4008200310 15002144251

Websitehttps://www.targetmol.cn/

Shanghai Yifei Biotechnology Co. , Ltd.

Telephone021-65675885 18964387627

Websitehttp://www.efebio.com

Nanjing Shizhou Biology Technology Co.,Ltd

Telephone025-85560043 15850508050

Websitehttp://www.synzest.com

Shanghai Aladdin Biochemical Technology Co.,Ltd.

Telephone6206333 13167063860

Websitehttp://www.aladdin-e.com/

Aikon International Limited

Telephone025-58851090 19370895928

Websitehttps://www.aikonchem.com/

Shanghai Amole Biotechnology Co., Ltd.

Telephone13370042665 18916960931

Websitehttps://www.amole.com.cn/

Guangzhou Ruidi Biotechnology Co., Ltd.

Telephone020-82099279 18988941402

Websitehttp://www.ubiochem.com/

Hangzhou MolCore BioPharmatech Co.,Ltd.

Telephone+86-057181025280; +8617767106207

Websitehttps://www.molcore.com/

1of3

Related Products

Send Inquriy

Animal Model:	Rats^[2].
Dosage:	0.6, 5 or 50 mg/kg.
Administration:	Orally (5 or 50 mg/kg), i.p. (5 mg/kg), i.v. 0.6 (0.6 mg/kg) (Pharmacokinetic Analysis).
Result:	Following oral administration, the dose of 5 mg/kg urinary and faecal excretion accounted for 5.8 + 0.7% and 96.4 + 2.1%. The dose of 50 mg/kg urinary and faecal excretion accounted for 14.0 + 4.0% and 78.4 + 2.4%. The proportions of unchanged drug and metabolites in urine were independent of the dose. The unchanged drug accounted for 81.6% of the faecal components after a dose of 5 mg/kg but this was reduced to 47.8%.

53671-71-9

Chemical Properties

Hazard Information

Uses

Definition

Biological Activity

in vivo

storage

Spectrum Detail

Supplier

Related Products